Elective nodal irradiation (ENI) doesn't appear to provide a clear benefit for patients with unresectable non–small-cell lung cancer (NSCLC)

SE Schild - International Journal of Radiation Oncology, Biology …, 2008 - redjournal.org
Elective nodal irradiation (ENI) is the irradiation of clinically uninvolved lymph node to
account for microscopic tumor invasion of these lymph nodes. Dr. Belderbos et al., under the …

Radiotherapy for locally advanced non-small cell lung cancer

N Girard, F Mornex - European Journal of Cancer, 2009 - Elsevier
Radiotherapy is one of the major therapeutic options in thoracic oncology. Besides surgery
for earlystage tumours, and chemotherapy for metastatic tumours, radiotherapy is the …

NSCLC in the elderly—the legacy of therapeutic neglect

J Weiss, C Langer - Current treatment options in oncology, 2009 - Springer
Opinion statement Although the majority of patients diagnosed with non-small cell lung
cancer (NSCLC) are elderly, most clinical trials available to guide care either exclude the …

Complex and controversial issues in locally advanced non‐small cell lung carcinoma

M Machtay, B Jeremic - Seminars in surgical oncology, 2003 - Wiley Online Library
Locally advanced non‐small cell lung carcinoma (NSCLC) presents enormous challenges
to clinicians and researchers. Because of the absence of metastatic disease, it is a …

Non‐conventional radiotherapy versus conventional radiotherapy for inoperable non‐small‐cell lung cancer: A meta‐analysis of randomized clinical trials

QN Zhang, DY Wang, XH Wang, T Hui… - Thoracic …, 2012 - Wiley Online Library
Background: The aim of this study was to evaluate the efficacy and safety of non‐
conventional radiotherapy versus conventional radiotherapy for inoperable non‐small‐cell …

Re-examining the role of elective nodal irradiation: finding ways to maximize the therapeutic ratio

DT Chang, RA Zlotecki, KR Olivier - American journal of clinical …, 2005 - journals.lww.com
Objective: Elective nodal irradiation (ENI) of regional lymphatics has been a foundational
paradigm for radiation oncologists in the treatment of nonsmall-cell lung cancer (NSCLC) …

The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non–small-cell lung cancer

SE Schild, WW Wong, SA Vora, MY Halyard… - International Journal of …, 2005 - Elsevier
Purpose: This analysis was performed to determine the long-term results of a Phase I trial
that included 3-times-a-day radiotherapy (TIDRT) and concurrent daily cisplatin (CDDP) for …

Place de la chimioradiothérapie concomitante dans le traitement des cancers bronchiques

N Girard, F Mornex - Bulletin du cancer, 2005 - jle.com
Le traitement des cancers bronchiques non à petites cellules localement évolués repose sur
la chimioradiothérapie concomitante exclusive; l'intérêt d'une séquence thérapeutique de …

[HTML][HTML] Innovations in the Radiotherapy of Non–Small Cell Lung Cancer

SE Schild, JA Bogart - Journal of Thoracic Oncology, 2006 - Elsevier
Background: This review was performed to describe recent innovations in the radiation
therapy of lung cancer. Methods: The literature was reviewed regarding recent research in …

Multidisciplinary approach in stage III non-small-cell lung cancer: standard of care and open questions

CV Ocaña, PG López, IM Trueba - Clinical and Translational Oncology, 2011 - Springer
Lung cancer is the most frequent cause of cancer death worldwide and its global incidence
has been steadily increasing during recent decades. A third of patients with newly …